Cargando…
Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients
Breast cancer is the predominant form of carcinoma among women worldwide, with 70% of advanced patients developing bone metastases, with a high mortality rate. In this sense, the bone marrow (BM) mesenchymal stem/stromal cells (MSCs) are critical for BM/bone homeostasis, and failures in their functi...
Autores principales: | BORZONE, FRANCISCO RAÚL, GIORELLO, MARÍA BELÉN, MARTINEZ, LEANDRO MARCELO, SANMARTIN, MARÍA CECILIA, FELDMAN, LEONARDO, DIMASE, FEDERICO, BATAGELJ, EMILIO, YANNARELLI, GUSTAVO, CHASSEING, NORMA ALEJANDRA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229310/ https://www.ncbi.nlm.nih.gov/pubmed/37305388 http://dx.doi.org/10.32604/or.2023.028104 |
Ejemplares similares
-
Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy
por: Sanmartin, María Cecilia, et al.
Publicado: (2022) -
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
por: Fernández Vallone, Valeria, et al.
Publicado: (2023) -
Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer
por: Labovsky, Vivian, et al.
Publicado: (2017) -
CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients
por: Giorello, María Belén, et al.
Publicado: (2023) -
CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
por: Martinez, Leandro Marcelo, et al.
Publicado: (2015)